Background: In India, the prevalence of low birth weight is high in women with a low body mass index (BMI), suggesting
Introduction
In India, the prevalence of low birth weight (LBW) 6 is high in women with low BMI (1) , suggesting that underweight women are unable to provide adequate nutrients, especially energy and protein, for growth of maternal tissues and the fetus. Studies have shown that protein synthesis is higher in healthy normalweight pregnant women in the second and third trimesters than in the first trimester (2) and that, in addition to the diet, an overall increase in body protein breakdown and a decrease in amino acid oxidation contribute the extra amino acids required for the increased protein synthesis (3, 4) . Furthermore, evidence that protein turnover increases to a greater extent in pregnant women whose BMI (kg/m 2 ) exceeds 25 compared with those with BMIs <25 suggests that amino acid supply is directly related to maternal BMI and protein turnover (5) . Because most of the amino acid supply is from endogenous protein breakdown, these findings imply that women with low BMIs will be unable to supply enough amino acids to satisfy the demands of pregnancy, especially in the fasting state. In an earlier study to test this hypothesis we reported that compared with pregnant normal-BMI Indian women, pregnant low-BMI Indian women did not have an increase in protein breakdown as pregnancy progressed from trimesters 1 to 2 (6) . Furthermore, although they oxidized more dietary protein, possibly to meet energy demands, they maintained net protein synthesis at the same rate as normal-BMI women because of increased dietary protein intake (6) . It is therefore possible that this inefficient use of dietary protein by low-BMI women could be overcome if they were supplemented with extra energy (and protein) during pregnancy. Another area of concern is whether underweight women can provide adequate amounts of methyl groups during pregnancy. Because of increased maternal and fetal tissue synthesis and deposition during pregnancy, an increased supply of methyl groups is necessary for the numerous methylation reactions associated with the synthesis of new proteins for the formation of new tissues. This notion is supported by data from a study in pregnant American women, which reported that methionine transmethylation and remethylation rates increase as pregnancy progresses from trimesters 1 to 3 (7) . This finding suggests that an impaired methionine cycle will negatively influence fetal protein synthesis and, hence, birth weight. To determine whether underweight pregnant women can increase methionine transmethylation and remethylation rates during pregnancy we conducted a study in Indian women with normal plasma folate and vitamin B-12 status in early and late pregnancy and reported that, as pregnancy progressed from trimesters 1 to 3, methionine transmethylation and remethylation rates did not increase, possibly because of inadequate methyl group precursors (8) . It is a distinct possibility that the smaller body protein mass of the underweight pregnant woman leads to slower production of the 2 primary suppliers of methyl groups, serine and glycine. If true, then providing extra dietary protein should elicit an increase in serine and glycine production. The present study was conducted to determine whether supplemental energy (300 kcal/d) and protein (15 g/d) to women with a low BMI during pregnancy will elicit an improvement in whole-body protein synthesis and serine and glycine fluxes and an overall improvement in pregnancy outcomes, especially maternal weight gain and newborn weight.
Methods
This study was conducted in the metabolic ward of St. JohnÕs Research Institute, Bangalore, India. The experimental protocol was approved by the Institutional Ethical Review Board of St. JohnÕs Medical College Hospital and by the Institutional Review Board for Human Subject Research of Baylor College of Medicine and affiliated hospitals. All of the study participants were informed of the purpose of the study, experimental procedures, and all potential risks involved before obtaining written consent at enrollment.
Participants and clinical care. Only pregnant women from the same dwelling area and similar socioeconomic background were invited to join the study. Women with multiple pregnancies, those with a clinical diagnosis of chronic illness (e.g., diabetes mellitus, hypertension, cardiac disease, thyroid disease, or epilepsy), and those who tested positive for hepatitis B surface antigen, HIV, or syphilis were excluded. Twenty-four pregnant women at <13 wk of gestation with low BMIs (#18.5) and normal plasma folate and vitamin B-12 status were identified and invited to participate. Gestational age was assessed from the first day of the last menstrual cycle and confirmed by ultrasound within 2 wk of the initial visit. At recruitment, routine antenatal tests were carried out as previously described (5, 6, 8) , and 5 mg folic acid/d was prescribed until the end of the first trimester. From the second trimester onward, the dose of this supplement was 0.5 mg/d; in addition, iron (45 mg elemental Fe/d) and calcium (1 g/d) supplements were prescribed until delivery, along with 2 doses of tetanus toxoid. No other multivitamin or multimineral preparations were prescribed.
Anthropometric measures. Maternal weight and height and the infantÕs weight were measured as we have previously described (6) . LBW and small for gestational age (SGA) were also defined as previously described (6) .
Habitual food intakes. An FFQ was administered at enrollment to obtain information on the habitual dietary intake for the preceding 3 mo and at each trimester visit. The FFQ was adapted from that developed for the urban middle class residing in South India (9) and validated against 24-h food recalls that were obtained 3 times during each trimester of pregnancy in 154 subjects (10) .
Study design. Whole-body and splanchnic leucine kinetics and serine, glycine, and urea fluxes were measured in the fasting and postprandial states at 2 different times during pregnancy: at the end of the first (12 6 1 wk of gestation) and at the beginning of the third (30 6 1 wk of gestation) trimesters. An 8-h-long continuous tracer infusion protocol was performed for 4 h in the fasting state and for 4 h in the postprandial state. An intravenous continuous infusion of 1-13 C-leucine was used to measure whole-body leucine kinetics, and orally administered 2 H 3 -leucine was used to measure splanchnic uptake of leucine during the postprandial state when the subjects were given small hourly meals that provided 1/12th of their habitual (or habitual plus supplemental) daily energy intake. These meals were made with a powdered dietary supplement (Ensure; Abbott HealthCare Private Ltd.), skimmed milk powder, and beet sugar. Because the composition of the mini-meals fed during the study was 65% carbohydrate, 15% protein, and 20% fat, and the average protein intake of both groups at trimesters 1 and 3 was ;12%, this meant that both groups received slightly more protein per hour during the fed part of each experimental protocol.
The supplement. After the trimester 1 experiment, 1 group of subjects started receiving a daily dietary supplement of energy and protein, which continued until delivery. Enrolled subjects were randomly assigned to either a supplemented or nonsupplemented group. In addition to their normal habitual diet, the supplemented group received a daily dietary supplement of 300 kcal/d and 15 g protein/d (i.e., 20% of energy from protein), provided as 3 small, round ''granola-type" treats, called ladoos in the local language, and made of crushed roasted peanuts, puffed rice, skimmed milk, clarified butter, and unrefined sugar. The other group continued to consume their habitual diet. A ladoo was consumed after each meal. To keep a record of compliance, the supplements were home-delivered by a social worker on alternate days, and the information on consumption was recorded.
Isotope infusion protocol. Subjects were admitted to the metabolic ward in the evening and ate dinner based on their habitual diet before 1900 h. Approximately 3 h later, an intravenous catheter (Jelco, 22 G; Medex Medical Ltd.) was inserted into the antecubital vein of 1 arm for the infusion of isotopes and another catheter was inserted into the dorsal vein of the contralateral hand for drawing blood samples. This catheter was kept patent with a slow saline drip. A warm blanket maintained at 60-65°C was placed around the hand to arterialize the venous blood collected. The extent of arterialization was assessed by measuring the hemoglobin saturation in a test sample, which was usually >95%.
A diagrammatic illustration of the 8-h-long infusion protocol is shown in Figure 1 . Sterile solutions of 1- C-leucine (6 mmol/kg), 2,2-2 H 2 -glycine (4 mmol/kg), 15 N-serine (4 mmol/kg), and 15 N 2 -urea (4 mmol/kg) for 8 h. Additional 1-mL blood and breath samples were taken every 15 min during hours 3 to 4 of the infusion as shown in Figure 1 . After 4 h of starting the infusions, the subjects consumed mini-meals every hour, which provided 1/12 of their habitual (or habitual plus supplemental) daily energy intake for the next 4 h. The oral 2 H 3 -leucine tracer dose was given with each mini-meal.
Additional 1-mL blood and breath samples were taken every 15 min during hours 7 to 8 as shown in Figure 1 . Total carbon dioxide excretion was determined with an open-circuit indirect calorimeter (MetaMax; Cortex) during the last hour of the fasting and the postprandial states. At the end of the infusion, the subjects were given a meal and discharged.
Laboratory analyses. Blood was drawn in prechilled tubes containing sodium fluoride and potassium oxalate and centrifuged 1200 3 g at 4°C, and the plasma removed and stored at 270°C for later analysis. Plasma amino acid concentrations were determined by reverse-phase ultraperformance LC as we have previously described (11) .
The plasma glycine and serine isotopic enrichments were measured by LC tandem MS on their DANS [5-(dimethylamino)-1-napthalene sulfonamide] derivatives. The ions were then analyzed by selected reaction monitoring mode. The transitions observed were precursor ions m/z 309, 310, and 311 to product ion m/z 170 at 19 electron volts for glycine and precursor ion m/z 339 and 340 to product ion m/z 170 at 20 electron volts for serine. The 2 H enrichment on plasma serine derived from the conversion of 2 H 2 -glycine was measured after the separation and subsequent pyrolysis utilizing the GC-thermal conversion-isotope ratio MS technique. Briefly, the amino acids in the plasma samples were first separated by Dowex AG-50W resin columns, then esterified by using propanol:HCl (3:1) by incubating at 70°C for 1 h. Subsequently, the esterified samples were acetylated by acetone:triethylamine:acetic anhydride (5:2:2) and incubated at 70°C for 20 min. The samples were then injected into the GC-thermal conversion-isotope ratio MS (Thermo Scientific Delta + XL) for separation followed by pyrolysis to hydrogen to determine 2 H enrichment on plasma serine. The isotopic enrichment of plasma urea was determined by electron impact ionization GC-MS analysis of its 2-pyrimidinol N-tert-butyldimethylsilyl derivative monitoring ions at m/z 153 to 155. The breath samples were analyzed for 13 C abundance in carbon dioxide by gas isotope-ratio MS, monitoring ions at m/z ratios 44 and 45.
Calculations. Total glycine (or serine or urea) flux (Q) was calculated as follows:
where IE Inf is the isotopic enrichment of the infusate, IE pl is the plateau isotopic enrichment of glycine (or serine or urea) in plasma, and I is the tracer infusion rate. Enrichment of 15 N-serine was calculated by subtracting the 2 H-serine enrichment (derived from the 2 H 2 -glycine tracer) from the total m+1 serine enrichment.
Endogenous flux was calculated in the fasting state by subtracting the tracer infusion rate and in the postprandial state by subtracting the tracer infusion rate plus dietary intake (except for urea). The rate of conversion of serine to glycine (Q Ser/Gly ) was calculated from the following:
where Q Gly is the total glycine flux, IE Gly is the plateau 15 N-glycine enrichment in plasma, and IE Ser is the plateau 15 N-serine enrichment in plasma.
In the case of leucine, flux was calculated by Equation 1 above with the use of the plateau isotopic enrichment of a-ketoisocaproic acid (a-KICA) derived from the 13 C-leucine tracer. Leucine oxidation (O), an index of protein catabolism, was calculated from the following:
where V : CO 2 is the rate of carbon dioxide excretion in the breath, 0.78 adjusts for the fraction of carbon dioxide produced that is recovered in expired air, IECO 2 is the plateau isotopic enrichment of breath carbon dioxide, and IE a-KICA is the plasma isotopic enrichment of a-KICA.
Nonoxidative leucine disposal (NOLD), that is, leucine used for protein synthesis, was calculated as Q minus O; and leucine balance, an index of net protein synthesis (postprandial state) or loss (fasting state), was calculated as the difference between leucine intake and leucine oxidation. The percentage of enteral leucine extracted by the splanchnic tissues was obtained as we have previously described (12):
where IE pEN and IE pIV are the plateau isotopic enrichments of the enteral ( 2 H 3 -) and intravenously administered ( Statistical analysis. Data are expressed as arithmetic means 6 SEs. Between-group (nonsupplemented compared with supplemented) and within-group (trimester 1 compared with trimester 3) differences in baseline characteristics and some pregnancy outcomes were assessed by unpaired and paired t tests, respectively. Within each prandial state, fasting or postprandial, differences between the groups in all other variables were analyzed by mixed-model (repeated-measures 2-factor) ANOVA with supplementation as the between factor and time of pregnancy (trimesters 1 and 3) as the repeated random factor. Post hoc comparisons were performed by using TukeyÕs test. Tests were considered 
Results
Of the 24 pregnant women who were enrolled in the study and who participated in the trimester 1 isotope infusion protocol, only 21 participated in the trimester 3 isotope infusion protocol: 11 in the nonsupplemented group and 10 in the supplemented group. One woman in each group lost her fetus before 30 wk of gestation and 1 woman in the supplemented group missed her infusion date because of travel. However, she continued participating in the study by taking her dietary supplement and her pregnancy outcome data are included.
Anthropometric measures and dietary intakes. As shown in Table 1 , there were no differences in age, parity, weight, BMI, and hemoglobin concentration between the groups at recruitment. All of the subjects had a low BMI (#18.5), and mean hemoglobin concentrations were at the lower end of the normal range in both groups. The habitual dietary intakes of the participants were estimated by the FFQ method. As shown in Table 2 , there were no significant differences between the groups or within a group from trimesters 1 to 3 in habitual dietary intakes of energy, protein, carbohydrate, fat, and the percentage of protein energy. Similarly, there were no significant differences between the groups or within a group in the intakes of the 3 amino acids 1 Values are means 6 SDs unless otherwise indicated. There were no significant differences between the 2 groups (unpaired t test or FisherÕs exact test). LBW, low birth weight; SGA, small for gestational age. 2 The nonsupplemented group had 2 subjects with fetal loss (1 at 38 wk due to fetal congenital heart disease after both infusions were completed, the other at 24.2 wk due to spontaneous abortion after the first infusion), whereas in the supplemented group, 1 subject had an abortion at 16 wk (after the first infusion).
of interest in this study: leucine, glycine, and serine. However, when the supplemental nutrients were added to the habitual intakes of the supplemented group during trimester 3, with the exception of carbohydrate, all of the intakes between the 2 groups were different. During trimester 3, protein intake expressed as a percentage of energy intake was not different in the supplemented group than in the nonsupplemented group (P = 0.06). However, the supplemented groupÕs intake during trimester 3 was significantly higher (P < 0.05) than during trimester 1. Pregnancy outcomes and newborn characteristics are presented in Table 3 . Among the 24 participants in the study, there were 2 fetal losses in the nonsupplemented group and 1 in the supplemented group. Maternal weight gain from the first to the third trimester, weeks 12-30 of gestation, and from weeks 30 to 36 were not different between the groups. There were also no differences in birth weight, length, and gestational age at birth between the groups. There was 1 premature delivery in the nonsupplemented group, whereas the supplemented group had no premature deliveries. The supplemented group had 2 SGA and 1 LBW infants, whereas the nonsupplemented group had no SGA infants and 1 LBW infant. Table 4 , in the fasting state there was a significant main effect of supplementation on endogenous leucine flux and NOLD, both of which decreased significantly in the supplemented group from trimesters 1 to 3 (P < 0.04). This, however, was due to the higher baseline values of this group, which were skewed by the higher values of 2 subjects. For example, their endogenous leucine fluxes were 46% and 40% higher than the mean of the group and their NOLD values were 49% and 48% higher. If the data from these 2 subjects are excluded, there is no significant main effect of supplementation on endogenous leucine flux and NOLD from trimesters 1 to 3. However, the robust regression followed by outlier identification (ROUT) test did not identify the data from these 2 subjects as outliers. Hence, they could not be left out. There was also a significant main effect of trimester on leucine balance, which improved from trimesters 1 to 3 (P = 0.04). In the postprandial state, there were significant main effects of trimester on leucine oxidation, which decreased from trimesters 1 to 3 in both groups (P = 0.02), and on leucine balance, which increased from trimesters 1 to 3 in both groups (P = 0.02). There were, however, no between-and within-group differences in any other leucine kinetic variable.
Leucine kinetics. As shown in
Urea, glycine, and serine kinetics. As shown in Table 5 , in both the fasting and postprandial states there was a significant effect of trimester on urea flux, which decreased from trimesters 1 to 3 in both groups (P < 0.01). As shown in Table 6 , in the fasting state there was no difference between the groups and within the groups from trimesters 1 to 3 in endogenous glycine flux, but flux derived from serine decreased significantly (P < 0.01) in both groups from trimesters 1 to 3. In the postprandial state there was a significant effect of trimester on dietary glycine intake, which was modestly higher in trimester 3 than in TABLE 4 Leucine kinetics in pregnant women with a low BMI at the end of trimester 1 and at the beginning of trimester 3 after supplementation with energy and protein or no supplementation 1 
Leucine kinetics
Nonsupplemented Supplemented Main effect, P T 1 (n = 11) T 3 (n = 11) T 1 (n = 10) T 3 (n = 10) S T P (S 3 T) 
Urea flux
Nonsupplemented Supplemented Main effect, P T 1 (n = 11) T 3 (n = 11) T 1 (n = 10) T 3 (n = 10) S T P (S 3 T) trimester 1 for both groups (P < 0.01). There were also significant effects of trimester on total and endogenous glycine fluxes and glycine flux derived from serine, all of which decreased from trimesters 1 to 3 in both groups (P < 0.03). As shown in Table 7 , in the fasting state there was a significant effect of trimester on endogenous serine flux, which decreased from trimesters 1 to 3 in both groups (P < 0.01). In the postprandial state there was a significant effect of trimester on dietary serine intake, which was modestly higher in trimester 3 than in trimester 1 for both groups (P < 0.01), and total and endogenous serine fluxes decreased from trimesters 1 to 3 in both groups (P < 0.01).
Plasma amino acid concentrations. As shown in Table 8 , there were no differences between the groups in any amino acid concentration. There were, however, significant main effects of trimester on the concentrations of a few amino acids. With respect to the dietary nonessential amino acids, in the fasting state asparagine, glutamate, alanine, and proline increased significantly from trimesters 1 to 3, whereas in the postprandial state glutamine and glutamate increased significantly from trimesters 1 to 3. With respect to the dietary essential amino acids, whereas threonine increased significantly from trimesters 1 to 3 in both the fasting and postprandial states, tryptophan decreased significantly from trimesters 1 to 3 in both the fasting and postprandial states.
Discussion
The primary aim of this study was to determine whether providing low-BMI women from week 12 of pregnancy to delivery with daily dietary supplements of 300 kcal/d and 15 g protein/d would elicit an improvement in whole-body protein synthesis and serine and glycine fluxes and an overall improvement in pregnancy outcomes, especially maternal weight gain and infant birth weight. The data show that supplementation had no significant effect on any variable of pregnancy outcome. It did not improve NOLD and balance, indexes of whole-body protein synthesis and net protein deposition (or loss) in the fasting and postprandial states. Similarly, it had no significant effects on glycine and serine fluxes. Finally, although urea flux decreased from trimesters 1 to 3 in both the supplemented and nonsupplemented groups, the magnitude of the reduction in flux was always much smaller in the supplemented group (9 and 17 mmol Á kg 21 Á h
21
) compared with the nonsupplemented group (32 and 46 mmol Á kg 21 Á h 21 ) in the fasting and postprandial states, respectively, suggesting that a substantial fraction of the supplemental protein was being oxidized.
There is evidence that fetal energy demands are met exclusively from oxidation of glucose and amino acids (13, 14) and increased glucose availability is met by an increase in maternal glucose production and gluconeogenesis in normal healthy women (15, 16) . The need for amino acids as a direct source of energy for the fetus, to support increased maternal gluconeogenesis, and as substrate for the synthesis of maternal and fetal proteins means that the demand for amino acids increases during pregnancy. If the poor pregnancy outcome of an underweight woman is due to her inability to provide sufficient amino acids and glucose to support a successful pregnancy, then early supplementation with energy and protein should, in theory, improve pregnancy outcomes. This was not the case, because the data from this study showed no differences between the supplemented and nonsupplemented groups of women in any of the amino acid kinetic variables or pregnancy outcomes. These 
Glycine kinetics
TABLE 7
Serine kinetics in pregnant women with a low BMI at the end of trimester 1 and at the beginning of trimester 3 after supplementation with energy and protein or no supplementation 1 
Serine kinetics
Amino acid and prandial state
Nonsupplemented Supplemented Main effect, P T 1 (n = 11) T 3 (n = 11) T 1 (n = 10) T 3 (n = 10) S T P (S 3 T) by guest on October 14, 2017
jn.nutrition.org findings add further support to the conclusion reached by a metaanalysis of data from several studies that underweight women do not benefit more from dietary energy and protein supplementation than do those who receive an adequate diet during pregnancy (17) . On the other hand, a more recent meta-analysis of data from 16 studies carefully chosen to assess the effect of a balanced protein-energy supplement-that is, a protein-energy content <25%-on pregnancy outcomes reported positive effects on weekly maternal weight gain and infant birth weights (18) . Subanalyses of smaller numbers of studies revealed 32% and 34% reductions in the prevalence of LBW and SGA infants, respectively. Although a balanced protein-energy supplement (20% protein-energy) was used in the present study, the failure to show any positive effect on pregnancy outcomes in all likelihood is due to the fact that the sample size was relatively small. Furthermore, as shown in Table 2 , the percentages of proteinenergy of the supplemented and nonsupplemented groups were not different at trimesters 1 and 3. Because most amino acid flux is from endogenous protein breakdown, if amino acid supply is directly related to maternal BMI and protein turnover (5) then underweight women with low BMIs will be unable to supply enough amino acids to satisfy the demands of pregnancy, especially in the fasting state. In an earlier study to test this hypothesis, we reported that pregnant low-BMI women used dietary protein less efficiently, yet they maintained net protein synthesis at the same rate as normal-BMI women because they increased their dietary protein intakes (6) . We therefore reasoned that this relatively inefficient use of protein by women with a low BMI could be overcome if they were supplemented with extra dietary energy during pregnancy. Our data showed that this was not the case because supplementation did not cause any increase in endogenous leucine flux and NOLD, indexes of protein breakdown and synthesis, from trimesters 1 to 3. There was, however, a modest but significant improvement in leucine balance from trimesters 1 to 3 in both groups in the fasting state, indicating an increase in net protein synthesis as pregnancy progresses. Although leucine oxidation did not decrease significantly from trimesters 1 to 3 in the fasting state, urea flux, an index of overall amino acid oxidation, decreased in both groups, suggesting an overall sparing of amino acids as pregnancy progresses. These findings suggest that in the fasting state low-BMI women can make the necessary protein metabolic adaptations reported for normal-BMI women as pregnancy progresses (19) .
In the postprandial state, although endogenous leucine flux did not change significantly from trimesters 1 to 3, there was a significant decrease in leucine oxidation in both groups, suggesting a sparing of amino acids. This translated into a significant increase in leucine balance, an index of net protein synthesis, in both groups. However, whereas leucine oxidation decreased by ;10 mmol Á kg 21 Á h 21 in both groups, suggesting they spared amino acids to the same extent, the magnitude of the decrease in urea flux was much smaller in the supplemented group, suggesting that the supplemented group did not spare amino acids to the same extent as the nonsupplemented group. That is, they seemed to be oxidizing the extra protein they were getting from the supplement, because their habitual energy and protein intakes were already adequate. In reality, this group was consuming a surfeit of energy compared with FAOrecommended requirements (20) ). In all likelihood this higher rate of protein oxidation is due to the fact that their intakes exceeded requirements at 30 wk of gestation. In fact, the protein intakes of both groups exceeded the WHO/FAO/United Nations Universityrecommended safe level of intake (21) (22) . Thus, although the protein intake of the nonsupplemented group at 30 wk of gestation was 20% lower, they conserved protein by oxidizing less than their supplemented counterparts at trimester 3. This may explain why pregnancy outcomes were not different between the groups. Finally, of interest is the fact that the habitual protein intakes of both groups at both trimesters were much higher than the Institute of MedicineÕs DRI value of 0.88 g Á kg 21 Á d 21 during pregnancy (23) .
In an earlier study, we reported that, unlike their normalweight American counterparts (7), underweight Indian women were unable to increase methionine transmethylation and homocysteine remethylation rates as pregnancy progresses from Supplemented Main effect, P T 1 (n = 11) T 3 (n = 11) T 1 (n = 10) T 3 (n = 10) S T P (S 3 T) trimesters 1 to 3, possibly because of an inadequate supply of the methyl group precursors glycine and serine and not because of folate and vitamin B-12 deficiency (8). We therefore reasoned that a slower protein breakdown rate due to the smaller body protein mass of an underweight pregnant woman will lead to slower production of serine and glycine and that providing extra dietary protein should elicit an increase in glycine and serine fluxes, hence availability of methyl groups for remethylation and transmethylation. Our data show that this was not the case because there were no differences in glycine and serine fluxes between the groups. In fact, serine fluxes decreased significantly from trimesters 1 to 3 in both groups and, although glycine flux decreased significantly only in the postprandial state its de novo synthesis from serine decreased in both the fasting and postprandial states, suggesting a shortage in the supply of serine to support glycine synthesis. Hence, the provision of extra dietary protein did not improve serine and glycine fluxes or the conversion of serine to glycine as pregnancy progressed to trimester 3. These findings support our conclusion from a previous study (8) that the inability of underweight women to increase methionine transmethylation and homocysteine remethylation may be related to their inability to increase the supply of serine and glycine, the 2 primary suppliers of methyl groups to the methionine cycle. In summary, providing women with low BMIs daily dietary supplements of 300 kcal/d and 15 g protein/d from week 12 of pregnancy did not improve any variable of pregnancy outcome, whole-body protein kinetics and serine and glycine fluxes. We conclude that dietary supplementation did not improve pregnancy outcome.
